Order Article Reprints

Butey S, Brown ML, Julson JR, Marayati R, Atigadda VR, Shaikh MG, Nazam N, Quinn CH, Shirley S, Stafman LL, et al. A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of TRIM29. International Journal of Molecular Sciences. 2025; 26(9):3933. https://doi.org/10.3390/ijms26093933

Butey, Swatika, Morgan L. Brown, Janet R. Julson, Raoud Marayati, Venkatram R. Atigadda, Maryam G. Shaikh, Nazia Nazam, Colin H. Quinn, Sorina Shirley, Laura L. Stafman, and et al. 2025. "A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of TRIM29" International Journal of Molecular Sciences 26, no. 9: 3933. https://doi.org/10.3390/ijms26093933

Butey, S., Brown, M. L., Julson, J. R., Marayati, R., Atigadda, V. R., Shaikh, M. G., Nazam, N., Quinn, C. H., Shirley, S., Stafman, L. L., & Beierle, E. A. (2025). A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of TRIM29. International Journal of Molecular Sciences, 26(9), 3933. https://doi.org/10.3390/ijms26093933